JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis

BACKGROUND: Gastric cancer (GC) is the most prevalent gastrointestinal tumor with an unfavorable clinical prognosis. GC patients are largely threatened owing to metastasis and drug resistance. Tumor angiogenesis plays an important role in the development of gastric cancer and is a challenge in the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jun-Jie, Ren, Yan-Lin, Shu, Chuan-Jun, Zhang, Yi, Chen, Min-Juan, Xu, Jin, Li, Jin, Li, Ai-Ping, Chen, Dong-Yin, He, Jing-Dong, Shu, Yong-Qian, Zhou, Jian-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310436/
https://www.ncbi.nlm.nih.gov/pubmed/32576271
http://dx.doi.org/10.1186/s13046-020-01617-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310436/
https://www.ncbi.nlm.nih.gov/pubmed/32576271
http://dx.doi.org/10.1186/s13046-020-01617-8

Ejemplares similares